Funding Rounds
VarmX

VarmX Series B (2023, $37M)

VarmX

Clinical-stage blood clotting treatment.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $37.09M

Investors